human
parechovirus
offici
known
parechoviru
peva
common
childhood
pathogen
potenti
sever
clinic
manifest
infant
yet
current
understand
peva
pathogenesi
epidemiolog
remark
limit
peva
share
similar
enterovirus
ev
research
biolog
clinic
aspect
peva
infect
highlight
differ
genera
within
peva
speci
one
intrigu
open
question
genotypespecif
diseas
associ
ie
sever
ill
almost
exclus
caus
genotyp
review
aim
look
enigma
discuss
current
known
preval
peva
pathogenesi
peva
virion
approxim
nm
diamet
compos
rna
genom
shield
outer
protein
capsid
lack
lipid
envelop
singlestrand
positivesens
ss
genom
nucleotid
nt
long
contain
singl
open
read
frame
flank
untransl
region
utr
nt
form
primari
secondari
rna
structur
crucial
replic
attach
viral
protein
call
vpg
intern
ribosom
entri
site
ire
within
facilit
direct
capindepend
translat
singl
larg
polyprotein
cleav
three
structur
protein
seven
nonstructur
protein
nt
termin
polyadenyl
tail
picornaviru
capsid
adopt
icosahedr
structur
see
figur
three
capsid
protein
assembl
protom
five
protom
togeth
form
pentam
total
pentam
result
final
icosahedron
defin
three
axe
symmetri
twofold
axe
along
edg
two
protom
ii
threefold
axe
along
protom
triangular
face
iii
fivefold
axe
along
pentam
vertic
howev
atom
structur
peva
reveal
sever
featur
uncommon
among
picornavirus
peva
capsid
surfac
rel
flat
miss
classic
hydrophob
pocket
target
small
molecul
capsid
inhibitor
block
viru
uncoat
seen
ev
peva
capsid
protein
cleav
matur
virion
furthermor
rna
packag
signal
appear
guid
peva
capsid
assembl
interestingli
procapsid
empti
particl
devoid
rna
genom
seen
mani
picornavirus
observ
peva
peva
lineag
diverg
recent
common
ancestor
around
year
ce
individu
type
might
diverg
recent
year
ago
picornavirus
rna
polymeras
peva
lack
proofread
activ
peva
high
mutat
rate
approxim
addit
high
mutat
rate
recombin
play
import
part
peva
evolut
recombin
shown
occur
frequent
breakpoint
mainli
locat
end
structur
region
junction
region
recombin
strain
breakpoint
locat
within
region
rare
accord
local
recombin
hotspot
picornavirus
enterovirus
locat
recombin
breakpoint
seem
correl
genet
divers
peva
genom
nt
amino
acid
variabl
higher
structur
region
nonstructur
region
illustr
antigen
pressur
structur
region
purifi
select
domin
nonstructur
region
recombin
might
play
import
role
establish
would
allow
mutat
structur
region
detriment
mutat
nonstructur
region
bypass
adopt
nonstructur
genom
segment
anoth
peva
strain
clear
indic
peva
circul
worldwid
detect
approxim
specimen
collect
children
clinic
suspicion
viral
infect
part
nation
ev
surveil
program
japan
hong
kong
denmark
finland
netherland
usa
furthermor
remark
high
preval
recent
demonstr
peva
children
malawi
specif
peva
genotyp
preval
vari
global
europ
usa
preval
follow
rare
report
asia
similar
europ
usa
preval
higher
divers
genotyp
report
india
pakistan
african
contin
preval
nearli
pev
genotyp
detect
indic
much
wider
circul
genotyp
differ
genotyp
distribut
report
exampl
pakistan
ghana
underlin
differ
preval
divers
contin
genet
variat
aris
errorpron
rnadepend
rna
polymeras
also
recombin
see
section
evolut
detail
frequenc
recombin
higher
among
sequenc
compar
isol
howev
recent
outbreak
neonat
sepsi
australia
caus
recombin
strain
peva
infect
also
show
clear
season
major
infect
record
late
summer
fall
interestingli
contrast
genotyp
report
circul
biannual
netherland
scotland
ultim
epidemiolog
studi
report
peva
preval
vari
greatli
cohort
age
clinic
present
sampl
type
collect
hamper
direct
comparison
increas
sequenc
effort
standard
diagnost
peva
test
lead
improv
insight
peva
epidemiolog
divers
parallel
seroepidemiolog
studi
determin
preval
neutral
antibodi
nab
specif
pathogen
sera
defin
popul
studi
provid
good
estim
viru
preval
potenti
immun
statu
differ
patient
group
circul
human
seroposit
nab
sharpli
increas
children
age
two
five
year
nearli
univers
adult
base
report
finland
netherland
japan
line
clinic
studi
show
common
genotyp
infect
occur
primarili
young
children
seropreval
nab
rel
high
finland
netherland
japan
recent
high
overal
seropreval
among
dutch
usa
australian
popul
shown
suggest
widespread
global
circul
agestratifi
analys
indic
infect
gener
occur
children
younger
year
howev
sinc
crossneutr
among
genotyp
observ
unequivoc
conclus
epidemiolog
genotyp
difficult
base
data
alon
peva
genotyp
receptor
involv
viral
bind
entri
identifi
remain
seen
univers
peva
receptor
present
nt
diverg
receptor
bind
capsid
sequenc
use
subgroup
peva
detect
genotyp
genotyp
contain
integrinbind
tripeptid
arginineglycineaspart
acid
rgd
motif
c
terminu
known
integrin
itg
heterodim
combin
bind
cellular
ligand
via
rgd
motif
surprisingli
picornavirus
echovirus
coxsackieviru
motif
shown
use
itg
receptor
structur
model
indic
rgd
motif
locat
icosahedr
fivefold
threefold
axe
capsid
surfac
delet
rgd
motif
result
loss
infect
therefor
sever
group
investig
role
itg
heterodim
infect
base
phage
display
screen
suggest
preferenti
use
itg
receptor
experi
employ
integrinblock
monoclon
antibodi
mab
indic
itg
primari
receptor
one
report
confirm
integrin
heterodim
involv
infect
other
describ
itg
high
affin
receptor
recent
report
infect
occur
via
itg
taken
togeth
result
indic
integrin
facilit
infect
use
specif
heterodim
may
cell
line
depend
itg
import
viru
bind
entri
cell
line
itg
may
exclus
receptor
vivo
studi
human
airway
epitheli
hae
cultur
found
effect
itg
block
infect
interestingli
strain
lack
ctermin
rgd
sequenc
isol
dutch
child
furthermor
lack
rgd
motif
itg
assum
involv
entri
howev
lack
rgd
motif
preclud
itg
bind
integrinligand
interact
occur
rgdindepend
manner
exampl
late
antigen
also
known
itg
shown
mediat
echoviru
infect
way
presenc
rgd
sequenc
exclud
involv
entri
receptor
itg
independ
infect
describ
rgd
motif
contain
virus
show
heparin
sulfat
hs
involv
infect
human
lung
adenocarcinoma
cell
line
howev
could
confirm
role
hs
hae
model
model
also
observ
rgd
rgdless
preferenti
infect
basal
cell
basolater
surfac
see
figur
either
close
relat
virus
util
separ
receptor
gain
entri
cell
type
perhap
share
yet
unidentifi
receptor
latter
one
interest
possibl
compon
antigenpres
major
histocompat
complex
mhc
initi
shown
involv
infect
rd
cell
line
howev
recent
report
show
block
significantli
reduc
infect
cell
line
coloc
observ
cell
line
side
note
bind
draw
interest
parallel
echovirus
peva
initi
classifi
echovirus
echoviru
use
itg
primari
receptor
itg
receptor
echovirus
recent
neonat
fc
receptor
fcrn
shown
panechoviru
receptor
fcrn
bind
partner
loss
express
render
cell
resist
echoviru
infect
perhap
peva
share
clinic
similar
echovirus
conclus
exact
receptor
use
peva
remain
open
question
itg
hs
play
role
viral
bind
identif
receptor
physiolog
relev
model
peva
step
forward
understand
parechoviru
pathogenesi
clinic
manifest
follow
peva
infect
rang
asymptomat
mild
symptom
sever
diseas
definit
associ
symptomatolog
establish
mani
peva
genotyp
causal
relationship
infect
number
clinic
condit
evid
associ
acut
gastroenter
upper
respiratori
tract
symptom
fever
rash
children
month
year
addit
rather
mild
symptom
often
caus
sever
diseas
infant
age
month
sever
outbreak
neonat
sepsislik
ill
due
infect
also
record
recent
australia
central
nervou
system
cn
syndrom
acut
flaccid
paralysi
mening
enceph
report
howev
cn
complic
commonli
associ
infect
instanc
longterm
neurodevelopment
sequela
report
must
note
longterm
neurolog
complic
rare
studi
need
formal
assess
longterm
outcom
epidem
myalgia
case
myocard
infect
adult
report
overal
peva
detect
adult
rare
peva
detect
fece
np
swab
blood
cerebrospin
fluid
csf
peva
epidemiolog
studi
perform
use
fece
sampl
children
younger
year
age
present
symptom
acut
gastroenter
furthermor
publish
report
focu
children
respiratori
neurolog
symptom
np
csf
serum
sampl
diagnost
detect
peva
perform
rtqpcr
target
untransl
region
utr
end
conserv
among
peva
genotyp
peva
genotyp
determin
partial
complet
sequenc
encod
region
genotyp
routin
perform
detect
viru
cultur
need
differ
cell
line
pev
compar
molecular
detect
method
less
sensit
viru
enter
bodi
host
immun
respons
engag
activ
counter
viral
infect
unfortun
inform
host
immun
respons
peva
scarc
gener
host
innat
adapt
immun
respons
appear
effici
control
peva
spread
infect
larg
selfresolv
pattern
recognit
receptor
tolllik
receptor
tlr
melanoma
differentiationassoci
gene
retino
acidinduc
gene
form
key
host
defens
mechan
intracellular
pathogen
case
import
recogn
singl
strand
rna
earli
infect
recognit
subsequ
activ
signal
pathway
ultim
lead
secret
proinflammatori
cytokin
interferon
tumor
necrosi
factor
interleukin
shown
infect
induc
type
interferon
respons
phosphoryl
upstream
ifn
regulatori
factor
recent
also
shown
activ
signal
downstream
protein
modul
pathway
known
investig
genotyp
differ
innat
immun
respons
use
adult
hae
model
system
observ
induc
significantli
stronger
activ
gene
involv
immun
inflammatori
signal
initi
host
respons
may
dictat
viral
spread
differ
clinic
outcom
role
tcell
immun
picornaviru
infect
welldefin
singl
studi
publish
tcell
immun
peva
infect
reactiv
capsid
protein
observ
adult
measur
tcell
prolifer
upon
exposur
recombin
protein
increas
tcell
prolifer
respons
capsid
indic
tcell
immun
could
play
role
peva
infect
respect
antibodi
respons
although
administr
intraven
immunoglobulin
ivig
immunodefici
adolesc
chronic
infect
reduc
viral
load
ivig
administr
associ
full
recoveri
infect
child
present
sever
dilat
cardiomyopathi
anim
studi
c
terminu
shown
immunogen
rabbit
immun
peptid
antigen
correspond
region
elicit
nab
term
neutral
antibodi
respons
rgd
motif
appear
play
role
human
monoclon
antibodi
epitop
map
ctermin
rgdregion
nab
target
rgd
motif
cross
neutral
peva
genotyp
contain
motif
immunodomin
epitop
includ
ntermin
region
capsid
encod
region
loop
capsid
surfac
first
month
life
matern
nab
protect
neonat
infect
matern
nab
protect
diseas
relat
peva
genotyp
except
sever
ill
neonat
lack
matern
nab
onset
diseas
mother
neonat
infect
show
low
ab
titer
innat
adapt
immun
respons
shown
differ
compar
peva
group
show
hae
cultur
induc
much
stronger
activ
gene
involv
immun
inflammatori
signal
neonat
immatur
still
develop
immun
system
strong
activ
could
result
sever
immunopatholog
support
fact
elev
level
proinflammatori
cytokin
system
inflammatori
respons
link
sever
pathogenesi
concept
cytokin
storm
well
establish
respiratori
pathogen
influenza
viru
human
coronaviru
neonat
sepsi
also
known
system
inflammatori
respons
syndrom
common
sever
clinic
manifest
point
toward
immunopatholog
infect
neonat
neonat
sepsi
associ
increas
vascular
permeabl
reduc
bloodbrain
barrier
bbb
function
viremia
increas
bbb
permeabl
result
neonat
sepsi
infect
may
allow
passiv
viru
leakag
cn
thu
detect
rna
csf
sampl
sever
ill
infant
may
sign
activ
viru
replic
cn
rather
consequ
system
inflammatori
respons
support
sever
studi
report
posit
csf
sampl
often
show
increas
white
blood
cell
count
howev
counter
group
shown
capabl
infect
neuron
cell
line
isol
replic
human
neuroblastoma
cell
line
effici
suggest
neural
tropism
therefor
viral
replic
cn
could
potenti
lead
enceph
mening
advers
longterm
neurodevelopment
outcom
seen
pediatr
infect
anoth
reason
exacerb
diseas
neonat
upon
infect
might
relat
humor
immun
other
shown
titer
nab
expect
level
protect
adult
year
support
lack
neutral
small
serosurvey
adult
wisconsin
usa
differ
nab
level
maintain
adult
cross
protect
antibodi
expect
shown
hyperimmun
serum
rais
rabbit
crossneutr
thu
low
nab
titer
women
childbear
age
may
lead
inadequ
matern
antibodi
protect
contribut
outbreak
infant
henc
specul
sever
present
young
infant
due
insuffici
adapt
excess
innat
host
immun
respons
current
specif
antivir
therapi
clinic
avail
peva
infect
treatment
option
limit
support
care
occasion
passiv
immun
administr
ivig
develop
target
antivir
drug
requir
detail
knowledg
viru
lifecycl
poorli
defin
studi
screen
ev
inhibitor
peva
indic
capsid
morpholog
proteas
function
host
factor
depend
differ
two
genera
instanc
pleconaril
ev
capsid
inhibitor
unabl
inhibit
peva
replic
due
differ
capsid
structur
wherebi
larg
amino
acid
side
chain
block
hydrophob
drug
bind
site
surfac
peva
similarli
ev
proteas
ev
inhibitor
golgi
transport
inhibitor
brefeldin
effect
ev
fail
inhibit
replic
anoth
host
factortarget
compound
antifung
agent
itraconazol
itz
shown
antivir
activ
itz
highli
interest
fdaapprov
drug
favor
safeti
profil
pediatr
patient
thu
itz
look
promis
treatment
research
pathogenesi
peva
need
design
target
antivir
therapi
given
matern
nab
appear
protect
sever
diseas
relat
peva
infect
develop
therapeut
mab
unmet
clinic
need
isol
character
structur
function
human
peva
mab
detail
found
sever
neutral
rgdcontain
genotyp
effici
one
mab
capabl
neutral
unfortun
antigen
distinct
prototyp
strain
circul
clinic
strain
nevertheless
data
repres
promis
step
toward
antibodi
treatment
peva
infect
review
discuss
epidemiolog
peva
summar
current
understand
peva
pathogenesi
howev
inform
preval
pathogenesi
peva
limit
peva
studi
reli
use
immort
cell
line
use
still
poor
model
pathogenesi
studi
anim
model
express
virusspecif
human
receptor
gold
standard
picornaviru
research
model
exist
peva
infect
newborn
mice
cynomolgu
monkey
experiment
infect
newborn
mice
appar
patholog
associ
order
elucid
entri
pathogenesi
identif
peva
receptor
critic
may
lead
gener
transgen
anim
model
altern
use
complex
organotyp
human
cell
cultur
model
could
way
forward
understand
peva
pathogenesi
one
model
welldifferenti
hae
cell
cultur
system
primari
human
epitheli
cell
airway
tissu
cultur
transwel
insert
group
use
model
studi
peva
infect
identifi
basal
cell
cell
type
infect
airway
recent
breakthrough
similarli
cultur
gut
epithelium
use
stem
cell
intestin
crypt
could
also
use
studi
peva
primari
cultur
system
term
organoid
develop
variou
organ
includ
brain
recapitul
cell
composit
organ
tissu
microenviron
vitro
valuabl
understand
pathogenesi
human
set
anoth
import
reason
expand
understand
peva
pathogenesi
address
lack
therapeut
option
current
rational
vaccin
develop
effort
antigen
profil
peva
genotyp
crucial
may
lead
discoveri
therapeut
monoclon
antibodi
altern
knowledg
peva
replic
cycl
could
result
develop
target
antivir
compound
perhap
one
intrigu
open
question
peva
biolog
genotyp
specif
diseas
associ
sever
ill
almost
exclus
caus
genotyp
hypothes
base
experiment
find
hae
model
observ
humor
respons
could
due
immun
respons
infect
experi
need
assess
whether
inde
case
futur
research
area
also
aim
character
molecular
cellular
determin
peva
immun
modul
across
variou
tissu
infant
adult
conclus
peva
common
childhood
pathogen
potenti
sever
clinic
diseas
infant
current
knowledg
limit
present
uniqu
opportun
picornavirologist
explor
clinic
relev
pathogen
anticip
identif
receptor
use
organotyp
model
drive
peva
research
field
forward
come
year
